-
DAT Neuroimaging Tracks hESC-mDA Maturation in Parkinson’s M
2026-05-29
Goggi et al. (2020) demonstrate that dopamine transporter (DAT) neuroimaging enables accurate, non-invasive assessment of human embryonic stem cell-derived midbrain dopaminergic neuron (hESC-mDA) maturation following transplantation in a preclinical Parkinson’s disease model. This quantitative approach advances the evaluation of cell therapy efficacy and offers a valuable tool for translational research in neurodegenerative diseases.
-
Salinomycin in HCC Research: Beyond Proliferation Inhibition
2026-05-29
Discover the role of Salinomycin, a polyether ionophore antibiotic, in hepatocellular carcinoma research. This article explores novel assay insights and practical protocol guidance to advance your cancer cell apoptosis studies.
-
Tankyrase Inhibition Suppresses HCC Growth via Hippo Pathway
2026-05-28
Jia et al. (2017) reveal that selective tankyrase 1/2 inhibition reduces proliferation of hepatocellular carcinoma (HCC) cells by destabilizing YAP through AMOTL1/2 stabilization, implicating the Hippo cascade as a vulnerability in HCC. These findings expand the mechanistic understanding of tankyrase inhibitors beyond Wnt/β-catenin signaling, suggesting broader anticancer therapeutic potential.
-
EGCG-Loaded 3D Printed TCP Scaffolds Enhance Bone Regenerati
2026-05-28
This study demonstrates that three-dimensional printed (3DP) tricalcium phosphate (TCP) scaffolds releasing (-)-Epigallocatechin gallate (EGCG) enhance osteogenic differentiation, suppress osteoclastogenesis, and promote vascularization in vitro. The findings suggest a promising multifunctional approach for bone defect repair post-trauma or tumor excision, integrating localized chemoprevention and tissue engineering.
-
Applied Use Cases of Merimepodib (VX-497) in Research Workfl
2026-05-27
Merimepodib (VX-497) empowers precise control over guanine nucleotide biosynthesis, enabling innovative designs in oncology, immunology, and antiviral research. This guide demystifies its use, from stepwise protocols to troubleshooting, translating recent metabolic insights into actionable laboratory strategies.
-
Hexetidine (NSC-17764): Data-Driven Solutions for Antimicrob
2026-05-27
This article provides scenario-based, evidence-backed guidance for life science researchers seeking reliable, reproducible outcomes in antimicrobial and cytotoxicity assays using Hexetidine (NSC-17764), SKU BA1327. Integrating real lab challenges, we highlight how APExBIO’s formulation offers validated performance, protocol versatility, and robust data support.
-
GSK-923295: Advancing CENP-E Inhibition in Translational Onc
2026-05-26
Explore the mechanistic, strategic, and translational impact of GSK-923295, a potent CENP-E inhibitor, in the context of mitotic fidelity, centromere biology, and cancer research. This article uniquely integrates new centromere maintenance insights with actionable guidance for researchers applying APExBIO’s advanced reagent in competitive oncology workflows.
-
Tankyrase Inhibition Suppresses HCC Growth via Hippo Pathway
2026-05-26
Jia et al. demonstrate that selective tankyrase 1/2 inhibitors, including G007-LK, suppress hepatocellular carcinoma (HCC) cell proliferation by destabilizing YAP signaling through Hippo pathway regulation. This mechanistic insight broadens the role of tankyrase inhibition beyond Wnt/β-catenin signaling, supporting the exploration of tankyrase inhibitors in diverse cancer models.
-
NHS-Biotin: Precision Biotinylation for Multimeric Protein L
2026-05-25
NHS-Biotin enables site-specific, efficient biotinylation of proteins and antibodies, powering advanced multimeric and intracellular protein labeling strategies. Its short spacer arm and membrane permeability make it indispensable for workflows requiring minimal steric hindrance and robust detection or purification, as highlighted by recent innovations in protein engineering.
-
Simvastatin Triggers Autophagy and Growth Arrest in Prostate
2026-05-25
This study establishes Simvastatin’s capacity to induce autophagy and inhibit proliferation in multiple prostate cancer cell lines, offering mechanistic insight into its anti-tumor effect. The findings reveal a potential therapeutic avenue for castration-resistant prostate cancer and highlight the synergy between Simvastatin and autophagy inducers.
-
BicD and MAP7 Synergistically Activate Drosophila Kinesin-1
2026-05-24
This study unravels how BicD and MAP7 independently and cooperatively relieve autoinhibition of Drosophila kinesin-1, enhancing microtubule-based cargo transport. The findings clarify distinct activation mechanisms and highlight the importance of adaptor and microtubule-associated protein crosstalk for processivity regulation.
-
Light-Inducible RNA Switches Enable Precision Gene Therapy C
2026-05-23
The reference study introduces a rationally engineered, light-inducible RNA-releasing protein (LIRP) that enables precise, optogenetic regulation of therapeutic gene translation in vivo. This technology allows on-demand, reversible control of gene expression, offering major advances in the safety and flexibility of gene therapies for chronic metabolic and retinal diseases.
-
BMS-345541: Precision IKK-1/IKK-2 Inhibitor for Inflammation
2026-05-22
BMS-345541 unlocks precise NF-κB pathway inhibition for inflammation and cancer research, enabling robust suppression of cytokine production and apoptosis induction. Its unique allosteric mechanism and validated in vitro and in vivo workflows make it a trusted choice for dissecting complex cellular signaling.
-
Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Usage Guide
2026-05-22
The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) addresses the need for precise detection of HMGB1 protein across research applications involving human, mouse, and rat samples. This reagent is intended for Western blot, immunohistochemistry, and flow cytometry workflows, but is not validated for diagnostic or therapeutic use.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-05-21
Wang et al. (2024) identify the METTL16-SENP3-LTF signaling axis as a critical regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). Their mechanistic findings reveal that METTL16-mediated m6A modification stabilizes SENP3 mRNA, promoting LTF accumulation and iron chelation, thereby suppressing ferroptotic cell death and advancing HCC progression.